Biliary tract cancer: our experience with gemcitabine treatment.
about
Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma.A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma.Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis.A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.Thymidine phosphorylase expression in gallbladder adenocarcinomas.Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study.
P2860
Q24814067-5B088083-A739-49A4-B8FB-6B99DF21D790Q33360400-E87DC46C-1BCD-47D2-BC64-AECDAD625832Q33368148-D05E918D-FA0A-4309-BE37-4985E56E3385Q36192053-DBC78D98-06FE-44D8-8AE4-2E83A973CB57Q36459140-0856E964-20D7-447C-85E8-4CE82BF1AF1FQ44136946-F33C8FAF-4918-414C-99F9-A8E287B2EC1FQ49178298-52EF8755-1DB3-4C76-98A0-C78B1745CC7E
P2860
Biliary tract cancer: our experience with gemcitabine treatment.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Biliary tract cancer: our experience with gemcitabine treatment.
@en
Biliary tract cancer: our experience with gemcitabine treatment.
@nl
type
label
Biliary tract cancer: our experience with gemcitabine treatment.
@en
Biliary tract cancer: our experience with gemcitabine treatment.
@nl
prefLabel
Biliary tract cancer: our experience with gemcitabine treatment.
@en
Biliary tract cancer: our experience with gemcitabine treatment.
@nl
P2093
P1433
P1476
Biliary tract cancer: our experience with gemcitabine treatment.
@en
P2093
P304
P356
10.1097/00001813-200010000-00006
P577
2000-10-01T00:00:00Z